New Key Statistics Module, Z-Score and F-Score
BJSE:837344 Key Ratios
Market Cap ¥ M | 1,721.17 |
Enterprise Value ¥ M | 2,068.42 |
P/E(ttm) | 53.53 |
PE Ratio without NRI | 53.53 |
Forward PE Ratio | -- |
Price/Book | 2.81 |
Price/Sales | 6.69 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.28 |
Revenue (TTM) ¥ M | 261.00 |
EPS (TTM) ¥ | 0.26 |
Beneish M-Score | -2.83 |
10-y EBITDA Growth Rate % | 7.60 |
5-y EBITDA Growth Rate % | -13.00 |
y-y EBITDA Growth Rate % | 39.40 |
EV-to-EBIT | 50.07 |
EV-to-EBITDA | 50.07 |
PEG | -- |
Shares Outstanding M | 121.81 |
Net Margin (%) | 12.28 |
Operating Margin % | 15.34 |
Pre-tax Margin (%) | 13.71 |
Quick Ratio | 1.68 |
Current Ratio | 1.84 |
ROA % (ttm) | 2.62 |
ROE % (ttm) | 5.33 |
ROIC % (ttm) | 3.63 |
Dividend Yield % | 0.53 |
Altman Z-Score | 2.24 |
BJSE:837344 Number of Guru Trades
BJSE:837344 Volume of Guru Trades
Gurus Latest Trades with BJSE:837344
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BJSE:837344 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beijing Tri Prime Gene Pharmaceutical Co Ltd Insider Transactions
No Available Data